Rhenman & Partners Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Rhenman & Partners Asset Management's AMGN Position: Q2 2026 in Review
Rhenman & Partners Asset Management reduced its Amgen (AMGN) stake by 22% in Q2 2026, selling an estimated $1.13M and leaving 11,900 shares worth $4.31M. The position accounts for 0.41% of the portfolio, ranked #78.
Rhenman & Partners Asset Management first reported a position in AMGN in Q1 2014 and has held it in 23 quarters since. The position peaked at $18.7M in Q3 2015. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Rhenman & Partners Asset Management held 11,900 shares of Amgen worth $4.31M as of Q2 2026.
- Rhenman & Partners Asset Management sold 3,300 Amgen shares in Q2 2026, an estimated $1.13M.
- Amgen made up 0.41% of Rhenman & Partners Asset Management's portfolio in Q2 2026, its #78 holding.
- Rhenman & Partners Asset Management first reported a position in Amgen in Q1 2014 and has held it in 23 quarters since.
- Rhenman & Partners Asset Management's Amgen position peaked at $18.7M in Q3 2015.
- 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Rhenman & Partners Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.